Authors:
McCloskey, E
Selby, P
De Takats, D
Bernard, J
Davies, M
Robinson, J
Francis, R
Adams, J
Pande, K
Beneton, M
Jalava, T
Loyttyniemi, E
Kanis, JA
Citation: E. Mccloskey et al., Effects of clodronate on vertebral fracture risk in osteoporosis: A 1-yearinterim analysis, BONE, 28(3), 2001, pp. 310-315
Authors:
Patel, S
Kwan, JTC
McCloskey, E
McGee, G
Thomas, G
Johnson, D
Wills, R
Ogunremi, L
Barron, J
Citation: S. Patel et al., Prevalence and causes of low bone density and fractures in kidney transplant patients, J BONE MIN, 16(10), 2001, pp. 1863-1870
Authors:
Lips, P
Cooper, C
Agnusdei, D
Caulin, F
Egger, P
Johnell, O
Kanis, JA
Kellingray, S
Leplege, A
Liberman, UA
McCloskey, E
Minne, H
Reeve, J
Reginster, JY
Scholz, M
Todd, C
de Vernejoul, MC
Wiklund, I
Citation: P. Lips et al., Quality of life in patients with vertebral fractures: Validation of the quality of life questionnaire of the European Foundation for Osteoporosis (QUALEFFO), OSTEOPOR IN, 10(2), 1999, pp. 150-160
Authors:
Bishop, HM
Cameron, DA
Coleman, R
Davies, AM
Dewar, JA
Evans, A
Evans, A
Harnett, AN
McCloskey, E
O'Donoghue, D
Pullicino, V
Robertson, J
Tillman, RM
van Schaick, SH
Citation: Hm. Bishop et al., The Guidelines for the management of metastatic bone disease in breast cancer in the United Kingdom, EUR J SUR O, 25(1), 1999, pp. 4-23